Rodríguez M A, Baroja M L, Leon-Ponte M, Stekman I L, Abadi I
Centro Nacional de Enfermedades Reumáticas, Hospital Universitario de Caracas, Venezuela.
Rheumatol Int. 1988;8(2):81-6. doi: 10.1007/BF00271839.
We examined the effect of treatment with piroxicam, a nonsteroidal antiinflammatory drug (NSAID), on immunoglobulin (Ig) and IgM-rheumatoid factor (IgM-RF) synthesis in vitro by lymphocytes of patients with rheumatoid arthritis (RA). Oral treatment with piroxicam induced a progressive decrease of spontaneous IgM-RF production by unstimulated lymphocyte cultures during 12 weeks of observation. Also, pokeweed mitogen (PWM)-driven Ig synthesis was significantly diminished and the effect on total IgM production was sustained until the end of the study. This modulation of humoral responses is consistent with the drop in RF sera level. In addition, we also showed that treatment with NSAIDs can decrease RF levels in the synovial space. NSAIDs may have a long-term beneficial effect in patients with RA due to their modulatory role of lymphocyte responses.
我们研究了非甾体抗炎药(NSAID)吡罗昔康对类风湿性关节炎(RA)患者淋巴细胞体外免疫球蛋白(Ig)和IgM类风湿因子(IgM-RF)合成的影响。在12周的观察期内,吡罗昔康口服治疗使未刺激的淋巴细胞培养物中自发IgM-RF产生逐渐减少。此外,商陆有丝分裂原(PWM)驱动的Ig合成显著减少,并且对总IgM产生的影响持续到研究结束。这种体液反应的调节与RF血清水平的下降一致。此外,我们还表明,NSAIDs治疗可降低滑膜间隙中的RF水平。由于NSAIDs对淋巴细胞反应的调节作用,它们可能对RA患者具有长期有益作用。